MedTrace Logo

Environmental Control as Add-on Therapy in Childhood Asthma

NCT02251379 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based controller medication will result in less controller medication requirement and allergic inflammation than controller medication alone among urban asthmatic children.

Conditions

Interventions

DRUG

Flovent Diskus

Inhaled corticosteroids

OTHER

Home Environmental Intervention

Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding

DRUG

Advair Diskus

inhaled corticosteroids + long-acting beta agonist

Sponsors & Collaborators

Principal Investigators

  • Elizabeth C Matsui, MD MHS · Johns Hopkins University

  • Meredith McCormack, MD MHS · Johns Hopkins University

  • Corinne Keet, MD PHD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-01
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02251379 on ClinicalTrials.gov